Akalay, Sara; 149721; Hosgood, Sarah A;
The increasing number of patients on the kidney transplant waiting list underlines the need to expand the donor pool and improve kidney graft utilization. By protecting kidney grafts adequately from the initial ischemic and subsequent reperfusion injury occurring during transplantation, both the number and quality of kidney grafts could be improved...
Van de Laar, SC Lafranca, JA Minnee, RC Papalois, V Dor, FJMF
Studies have been carried out to investigate the effect of a prolonged cold ischaemia time (CIT) on the outcomes of living donor kidney transplantation (LDKT). There is no clear consensus in the literature about the effects of CIT on LDKT outcomes, and therefore, we performed a systematic review and meta-analysis to provide evidence on this subject...
Ollauri-Ibáñez, Claudia Astigarraga, Itziar
Published in
Cancers
Cancer is an important cause of death in childhood. In recent years, scientists have made an important effort to achieve greater precision and more personalized treatments against cancer. But since only a few pediatric patients have identifiable therapeutic targets, other ways to stop the neoplastic cell proliferation and dissemination are needed. ...
Teblick, Arno; Philipse, Ester; Vleut, Rowena; Massart, Annick; Couttenye, Marie M; Bracke, Bart; Hartman, Vera; Chapelle, Thiery; Roeyen, Geert; Ysebaert, Dirk K;
...
BACKGROUND: Delayed graft function (DGF) remains a clinically relevant problem in the post-transplant period, especially in patients with a renal graft from a "donation after cardiac death" (DCD) donor. Controversy exists around the optimal perioperative fluid therapy in such patients. These patients may benefit from a perioperative saline loading ...
De Beule, Julie; 87987; Jochmans, Ina; 60176;
The final decision to accept an organ for transplantation remains a subjective one. With "poor organ quality" commonly cited as a major reason for kidney discard, accurate, objective, and reliable quality assessment is essential. In an era of increasingly higher-risk deceased donor kidneys, the catch is to accept those where the risk-benefit scale ...
Bellini, MI Charalampidis, S Herbert, PE Bonatsos, V Crane, J Muthusamy, A Dor, FJMF Papalois, V
Introduction. We present our experience with hypothermic machine perfusion (HMP) versus cold storage (CS) in relation to kidney transplant outcomes. Methods. Retrospective analysis of 33 consecutive HMP kidney transplant outcomes matched with those of 33 cold stored: delayed graft function (DGF), length of hospital stay (LOS), estimated glomerular ...
Territo, Angelo Gausa, Lluis Alcaraz, Antonio Musquera, Mireia Doumerc, Nicolas Decaestecker, Karel Desender, Liesbeth Stockle, Michael Janssen, Martin Fornara, Paolo
...
Published in
BJU international
To evaluate functional results, graft survival and late complications in patients who underwent robot-assisted kidney transplantation (RAKT) and who had a minimum of 1 year of follow-up data, and to analyse the correlations between surgical data and functional results at a minimum of 1-year postoperatively and between renal function in the immediat...
Chiodini, Benedetta; Herman, Jean; 10479; Lolin, Ksenija; Adams, Brigitte; Hennaut, Elise; Lingier, Pierre; Mikhalski, Dimitri; Schurmans, Thierry; Knops, Noel; 69329; Wissing, Karl M;
...
Kidney transplantation (KT) is often delayed in small children because of fear of postoperative complications. We report early- and long-term outcomes in children transplanted at ≤15 kg in the two largest Belgian pediatric transplant centers. Outcomes before (period 1) and since the introduction of basiliximab and mycophenolate-mofetil in 2000 (per...
Neuberger, James M; Bechstein, Wolf O; Kuypers, Dirk; 46355; Burra, Patrizia; Citterio, Franco; De Geest, Sabina; 5386; Duvoux, Christophe; Jardine, Alan G; Kamar, Nassim; Krämer, Bernhard K;
...
Short-term patient and graft outcomes continue to improve after kidney and liver transplantation, with 1-year survival rates over 80%; however, improving longer-term outcomes remains a challenge. Improving the function of grafts and health of recipients would not only enhance quality and length of life, but would also reduce the need for retranspla...
Hamaoui, K Gowers, S Boutelle, M Cook, TH Hanna, G Darzi, A Smith, RA Dorling, A Papalois, V
Background: Hypothermic machine organ perfusion (HMP) offers opportunity to manipulate grafts with pharmacological agents prior to transplantation. Pre-treating organs with novel cytotopic anti-coagulant peptides that localise to endothelial cell membranes could ameliorate microvascular thrombotic sequelae post-transplantation. We describe experime...